Urinary-type plasminogen activator receptor/α3β 1 integrin signaling, altered gene expression, and oral tumor progression

Molecular Cancer Research

Volumn 8, Issue 2, 2010, Pages 145-158

  Ghosh, Supurna ^a,c   Koblinski, Jennifer ^a   Johnson, Jeffrey ^b   Liu, Yueying ^b   Ericsson, Aaron ^b   Davis, J Wade ^b   Shi, Zonggao ^b   Ravosa, Matthew J ^b   Crawford, Susan ^a   Frazier, Shellaine ^b   Stack, M Sharon ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b University of Missouri   (United States)

^c Revalesio Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; COMPLEMENTARY DNA; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE; UROKINASE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; CYTOLOGY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; VASCULARIZATION; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA3BETA1; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE HYDROLASES; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

MURINAE;

EID: 77249112380     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0045     Document Type: Article

References (66)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999:33-64.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
3. Gorsky M, Epstein BJ, Oakley C, Le ND, Hay J, Stevenson-Moore P. Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:546-52.
4. Shiboski CH, Schmidt BL, Jordan RCK. Tongue and tonsil carcinoma: increasing trends in the US population ages 20-44 years. Cancer 2005;103:1843-9.
5. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007;26:645-62.
6. Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR. The National Cancer Data Base report on squamous cell carcinoma of the base of the tongue. Head Neck 2004;26:660-74.
7. Macfarlane G, Boyle P, Evstifeeva TV, Robertson C, Scully C. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control 1994;5: 2259-265.
8. Ziober AF, Patel KR, Alawi F, et al. Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Can Res 2006;12:5960-71.
9. Nagata M, Fujita H, Ida H, et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 2003;106:683-9.
10. Shi Z, Stack MS. Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity. Biochem J 2007;407:153-9.
11. Shi Z, Stack MS. Molecules of cell adhesion and extracellular matrix proteolysis in oral squamous cell carcinoma. Histol Histopathol. In press 2010.
12. Wang J, Guo F, Wei H, Dong J, Wu J. Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma. Br J Oral Maxillofac Surg 2006; 44:515-9.
13. Curino A, Patel V, Nielsen BS, et al. Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography. Oral Oncol 2004;40:1026-32.
14. Clayman G, Wang SW, Nicolson GL, et al. Regulation of urokinasetype plasminogen activator expression in squamous cell carcinoma of the oral cavity. Int J Cancer 1993;54:73-80.
15. Nozaki S, Endo Y, Kawashiri S, et al. Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis. Oral Oncol 1998;34:58-62.
16. Lindberg P, Larsson A, Nielsen BS. Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin γ2 chain is an early coordinated event in incipient oral squamous cell carcinoma. Int J Cancer 2006;118:2948-56.
17. Yasuda T, Sakata Y, Kitamura K, Morita M, Ishida T. Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck. Head Neck 1997;19:611-6.
18. Hundsdorfer B, Zeilhofer HF, Bock KP, et al. Tumor associated urokinase type plasminogen activator and its inhibitor PAI1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity-clinical relevance and prognostic value. J Craniomaxillofac Surg 2005;33:191-6.
19. 1 integrin in oral keratinocytes. J Biol Chem 2000;275:23869-76.
20. 1 integrin association in proteinase regulatory pathways. J Biol Chem 2006;281:13021-29.
21. Fidler IJ. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 1986;5:29-49.
22. Morifuji M, Taniguchi S, Sakai H, Nakabeppu Y, Ohisi M. Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability. Am J Pathol 2000;156:1317-26.
23. Myers JN, Holsinger FC, Jasser SA, Bekele BN, Fidler IJ. An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 2002;8:293-8.
24. Yazici YD, Kim S, Jasser SA, et al. Antivascular therapy of oral tongue squamous cell carcinoma with PTK787 . Laryngoscope 2005;115:2249-55.
25. Pettus JR, Johnson JJ, Shi Z, et al. Multiple kallikrein (KLK 5,7,8, and 10) expression in squamous cell carcinoma of the oral cavity. Histol Histopathol 2009;24:197-207.
26. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article3.
27. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. In: Bioinformatics and computational biology solutions using R and Bioconductor. New York: Springer; 2005, p. 397-20.
28. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
29. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002;30:e15.
30. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
31. Dennis G, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4:3-26.
32. Al Moustafa A, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;21:2634-40.
33. Lengyel E, Gum R, Stepp E, Juarez J, Wang H, Boyd D. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line. J Cell Biochem 1996;61:430-43.
34. Barnes L. World Health Organization classifications of tumors: pathology and genetics of head and neck tumours. pp. 174-5Lyon: IARC Press; 2005.
35. Fu YS, Wenig BM, Abeymayor E, Wenig BL. Head and neck pathology with clinical correlations. p. 474Philadelphia: Churchill Livingstone; 2001.
36. Gnepp DR. Diagnostic surgical pathology of the head and neck. pp. 22-6Philadelphia: WB Saunders Co.; 2001.
37. 1 regulate matrix adhesion and cell-cell contact. J Cell Biol 2003;163:177-88.
38. Borgono CA, Iacovos PM, Eleftherios PD. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004;2: 257-80.
39. Clements JA, Willemsen NM, Myers SA, Dong Y. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit Rev Clin Lab Sci 2004;41:265-312.
40. Providence KM, Higgins SP, Mullen A, et al. SERPINE1 (PAI1) is deposited into keratinocyte migration trails and required for optimal monolayer wound repair. Arch Dermatol Res 2008;300:303-10.
41. Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH. Evolving role of uPA/uPAR system in human cancers. Cancer Treat Res 2008;34: 122-36.
42. Andreasen PA. PAI-1-a potential therapeutic target in cancer. Curr Drug Targets 2007;8:1030-41.
43. Marinkovich MP. Tumor microenvironment: laminin 332 in squamous cell carcinoma. Nat Rev Cancer 2007;7:370-80.
44. Tsuruta D, Kobayashi H, Imanishi H, Sugawara K, Ishii M, Jones JC. Laminin-332-integrin interaction: a target for cancer therapy? Curr Med Chem 2008;15:1968-75.
45. Mognetti B, DiCarlo F, Berta GN. Animal models in oral cancer research. Oral Oncol 2006;42:448-60.
46. Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE. Tongue cancer: is there a difference in survival compared with other subsites in the oral cavity?. J Oral Maxillofac Surg 2007;65:229-36.
47. Suhr ML, Dysvik B, Bruland O, et al. Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users. Oncol Rep 2007;18:1061-75.
48. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005;5:127-35.
49. Roepman P, Wessels KFA, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182-6.
50. Zhang X, Su L, Pirani AA, et al. Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis. Clin Exp Metastasis 2006;23: 209-22.
51. Ossowski L, Aguirre-Ghiso JA. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 2000;12:613-20.
52. Jo M, Thomas KS, Wu L, Gonias SL. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling. J Biol Chem 2003;278:46692-8.
53. Blasi F, Carmeliet P. uPAR: a versatile signaling orchestrator. Nat Rev Mol Cell Biol 2002;3:932-43.
54. Kishimoto K, Sasaki A, Yoshihama Y, Mese H, Tsukamoto G, Matsumura T. Expression of vascular endothelial growth factor C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol 2003;39:391-6.
55. Tanigaki Y, Nagashima Y, Kitamura Y,Matsuda H,Mikami Y, TsukudaM. The expression of vascular endothelial growth factor-A and -C and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma. Int J Mol Med 2004;14: 389-95.
56. Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K, Hamakawa H. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol 2004;40:13-20.
57. Miyahara M, Tanuma J, Sugihara K, Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 2007;110: 1287-94.
58. Siriwardena B, Kudo Y, Ogawa I, Udagama K, Tilakaratne WM, Takata T. VEGF-C is associated with lymphatic status and invasion in oral cancer. J Clin Pathol 2008;61:103-8.
59. Pampalakis G, Sotiorpoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta 2007;1776:22-31.
60. Paliouras M, Borgono C, Diamandis EP. Human tissue kallikreins: the cancer biomarker family. Cancer Lett 2004;249:61-79.
61. Vairaktaris E, Yapijakis C, Serefoglou Z, et al. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 2006;42:888-92.
62. Driemel O, Dahse R, Hakim SG, et al. Laminin-5 immunocytochemistry: a new tool for identifying dysplastic cells in oral brush biopsies. Cytopathology 2997;18:329-30.
63. Chen C, Mendez E, Houck J, et al. Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2008;17:2152-62.
64. Kuratomi Y, Kumamoto M, Kidera K, et al. Diffuse expression of laminin γ2 chain in disseminating and infiltrating cancer cells indicates a highly malignant state in advanced tongue cancer. Oral Oncol 2006;42:73-6.
65. Zhang X, Liu Y, Gilcrease MZ, et al. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 2002;95:1663-72.
66. Henson B, Li F, Coatney DD, et al. An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. J Oral Pathol Med 2007;36:363-70.